Abstract:
PURPOSE: A natural calcium compound is provided to enhance calcium absorption rate with high ionizing degree and to ensure blood glucose reduction. CONSTITUTION: A composition for controlling blood glucose contains ionized calcium as an active ingredient. The ionized calcium is a shell ionized calcium. A method for manufacturing the ionized calcium comprises: a step of pulverizing shells at 1.5-10 cm; a step of pilling the pulverized shell inside a plasticizing furnace and plasticizing by 1200°C; a step of blocking heat and cooling by 200-400°C and by 100-150°C; and a step of cooling by room temperature. A health food for controlling blood glucose contains ionized calcium as an active ingredient.
Abstract:
본 발명은 원지, 석창포, 인삼, 당귀, 은행잎, 오미자 및 천궁으로 이루어진 혼합 추출물을 함유하는 조성물에 관한 것으로서, 이러한 조성물은 인체에 안전하며, 상기 약재들의 상승 작용에 의하여 기억력을 향상시키는 효과가 뛰어나다. 원지, 석창포, 기억력 향상
Abstract:
본 발명은 1-베타메틸카바페넴 유도체 및 그 제조에 사용되는 중간체에 관한 것으로서, 상기 1-베타메틸카바페넴 유도체는 하기 화학식 1의 구조를 갖는 것을 특징으로 한다.
(상기 화학식 (I)에서, X는 O, S, N 이고, Y는 옥소, 히드록시, 옥심, 메톡시이민이다.) 본 발명에 의한 1-베타메틸카바페넴 유도체는 시클릭아민기가 포함된 티올 유도체를 치환시킴으로써 항균 활성이 우수하고, 내성균에 강한 효과가 있다. 따라서 본 발명에 의한 1-베타메틸카바페넴 유도체는 항생제로서 유용하게 사용할 수 있다. 항생제, 카바페넴, 사이클릭아민, 피롤리딘
Abstract:
A composition for curing a hangover and a preparation method thereof are provided to restore NADH from over-consumed NAD in aldehyde production process by oxidation promotion, promote alcohol decomposition, and inhibit aldehyde concentration and reactive oxygen species produced from alcohol decomposition without side effects on human body. The composition for curing the hangover comprises 10-15 parts by weight of Angelica gigas Nakai, 10-15 parts by weight of Thuja orientalis L., 9-10 parts by weight of Astragalus membranaceus(FISCH) Bunge, 9-10 parts by weight of Atractylodes macrocephala KOIDZ, 9-10 parts by weight of Rehmannia preparata Libosch, 9-10 parts by weight of Cnidium officinale, 9-10 parts by weight of Citrus unshiu MARKOVICH., 9-10 parts by weight of Polygonatum sibiricum Redoute, 9-10 parts by weight of Polygala tenuifolia WILLD., 4-5 parts by weight of Hovenia dulcis thunb and 4-5 parts by weight of Pueraria thunbergiana BENTH.
Abstract:
본 발명은 동충하초와 여주를 함유하는 혈당강하용 조성물에 관한 것으로, 보다 상세하게는 누에동충하초, 여주 및 마그네슘을 함유하는 혈당강하용 조성물에 관한 것이다. 본 발명에 따른 혈당강하용 조성물은 동물 실험에서 평균 60 % 이상의 혈당강하효과를 나타내었으며, 이는 각 개별성분으로는 달성할 수 없는 우수한 혈당 강하 효능이라 할 것이다.
Abstract:
본 발명은 할로겐이 치환된 디페닐에테르 유도체의 제조방법에 관한 것으로, 더욱 구체적으로 디페닐에테르 화합물을 출발물질로 하여 산용액하에서 할로겐산나트륨을 혼합하여 할로겐화하는 단계; 프리델-크래프트 아실화 반응을 수행하는 단계; 과산화 수소와 무수말린산을 이용하여 산화시키는 단계; 및 가수분해 단계로 이루어진 할로겐이 치환된 디페닐에테르 유도체의 제조방법에 관한 것으로, 종래 염소화 반응에서 사용되는 염소기체 대신 할로겐산나트륨 및 산용액을 사용하므로, 대규모 생산하는데 있어서 비용 및 제조시간이 절약되며, 정량적인 반응에 의해 부생성물을 줄일 수 있으며, 이로 인해 수율을 더욱 높일 수 있으며, 또한 전 과정에서 단일 용매를 사용할 수 있어 공정상의 조작을 단순히 하여 경제성 있는 제조방법이다.
Abstract:
PURPOSE: Provided is a vinyl carbamoyl azide derivative, which is more stable than a conventional carbamoyl azide derivative and has an effective sterilizing power against mold harmful to the crops. CONSTITUTION: The vinyl carbamoyl azide derivative represented by the formula 1 is produced by reacting an isocyanate compound(R1NCO) and hydrazoic acid(NH3) or sodium azide(NaN3). In the formula, R1 is at least one C1-C6 alkyl, or furyl or phenyl capable of being substituted by at least one substituent selected from the group consisting of halogen, C1-C6 alkoxy, and nitro.
Abstract:
PURPOSE: A method for preparing a diphenyl ether derivative substituted with halogen is provided, to reduce the cost and the preparation time by employing a sodium salt of halogen acid and an acid solution instead of chlorine gas, to reduce the amount of by-product and to improve the yield. CONSTITUTION: The method comprises the steps of reacting diphenyl ether represented by the formula 2 with sodium salt of halogen acid in the presence of an acid solution to prepare 2,4,4'-trihalogen diphenyl ether represented by the formula 3; reacting the obtained compound of the formula 3 with acetyl chloride in the presence of an aluminium catalyst to prepare 2,4,4'-trihalogen-2'-acetyldiphenyl ether represented by the formula 4; reacting the obtained compound of the formula 4 with maleic anhydride in the presence of hydrogen peroxide to prepare 2,4,4'-trihalogen-2'-acetoxydiphenyl ether represented by the formula 5; and reacting the obtained compound of the formula 5 with a strong base to prepare 2,4,4'-trihalogen-2'-hydroxydiphenyl ether represented by the formula 1, wherein X is Cl or Br.
Abstract:
PURPOSE: Provided is a manufacturing method for dialkyl(4-hydroxy-3,5-di(t-butyl)benzyl)phosphonate(DAP) in high yield , thereby mass-producing DAP without generating carcinogens not by using a strong base. CONSTITUTION: Dialkyl(4-hydroxy-3,5-di(t-butyl)benzyl)phosphonate is manufactured by reacting N, N-dialkyl-(4-hydroxy-3,5-di(t-butyl)benzyl)amine or its salt with dialkyl phosphate or trialkyl phosphate in the presence of an alkylating agent, at 60-120 deg.C.
Abstract:
PURPOSE: Provided are antibiotic 1-β-methyl-carbapenem derivatives of the formula(2) substituted with novel bicyclic thiol derivatives represented by the formula(1) which have stability against DHP-1 enzyme and are effective against resistant bacteria. CONSTITUTION: The method for preparing thiols and carbapenem derivatives comprises the steps of: carrying on the reaction scheme(1) to make thiols and combining them with carbapenem derivatives to make the final product of the formula(2). In the formula(1) and the formula(2), R1 is methyl or ethyl group and R2 is C1-6 alkyl such as methyl, ethyl, propyl, C1-6 cycloalkyl or alkyl substituted with phenyl, vinyl and hydroxyl group.